# NOV Inc.: financial statements, quarterly

NOV · NYSE · CIK 1021860 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nov.md) · [Financials](/companies/nov/financials.md) · [Filings](/companies/nov/filings.md) · [Insiders](/companies/nov/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nov/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,093](/filings/0000950170-24-087179.md) | [2,185](/filings/0000950170-24-117316.md) | [2,343 d](/filings/0001193125-26-048350.md) | [2,155](/filings/0000950170-25-059817.md) | [2,216](/filings/0000950170-25-099476.md) | [2,191](/filings/0001193125-25-253755.md) | [2,308 d](/filings/0001193125-26-048350.md) | [2,103](/filings/0001193125-26-185866.md) | [2,188](/filings/0000950170-25-099476.md) | [2,176](/filings/0001193125-25-253755.md) | [2,277 d](/filings/0001193125-26-048350.md) | [2,052](/filings/0001193125-26-185866.md) |
| Cost of revenue | $m | [1,636](/filings/0000950170-24-087179.md) | [1,717](/filings/0000950170-24-117316.md) | [1,846 d](/filings/0001193125-26-048350.md) | [1,697](/filings/0000950170-25-059817.md) | [1,626](/filings/0000950170-25-099476.md) | [1,722](/filings/0001193125-25-253755.md) | [1,815 d](/filings/0001193125-26-048350.md) | [1,656](/filings/0001193125-26-185866.md) | [1,742](/filings/0000950170-25-099476.md) | [1,764](/filings/0001193125-25-253755.md) | [1,815 d](/filings/0001193125-26-048350.md) | [1,673](/filings/0001193125-26-185866.md) |
| Gross profit | $m | [457](/filings/0000950170-24-087179.md) | [468](/filings/0000950170-24-117316.md) | [497 d](/filings/0001193125-26-048350.md) | [458](/filings/0000950170-25-059817.md) | [590](/filings/0000950170-25-099476.md) | [469](/filings/0001193125-25-253755.md) | [493 d](/filings/0001193125-26-048350.md) | [447](/filings/0001193125-26-185866.md) | [446](/filings/0000950170-25-099476.md) | [412](/filings/0001193125-25-253755.md) | [462 d](/filings/0001193125-26-048350.md) | [379](/filings/0001193125-26-185866.md) |
| Selling, general and administrative | $m | [276](/filings/0000950170-24-087179.md) | [285](/filings/0000950170-24-117316.md) | [336 d](/filings/0001193125-26-048350.md) | [296](/filings/0000950170-25-059817.md) | [277](/filings/0000950170-25-099476.md) | [275](/filings/0001193125-25-253755.md) | [286 d](/filings/0001193125-26-048350.md) | [295](/filings/0001193125-26-185866.md) | [303](/filings/0000950170-25-099476.md) | [305](/filings/0001193125-25-253755.md) | [300 d](/filings/0001193125-26-048350.md) | [332](/filings/0001193125-26-185866.md) |
| Operating income | $m | [181](/filings/0000950170-24-087179.md) | [183](/filings/0000950170-24-117316.md) | [161 d](/filings/0001193125-26-048350.md) | [162](/filings/0000950170-25-059817.md) | [313](/filings/0000950170-25-099476.md) | [194](/filings/0001193125-25-253755.md) | [207 d](/filings/0001193125-26-048350.md) | [152](/filings/0001193125-26-185866.md) | [143](/filings/0000950170-25-099476.md) | [107](/filings/0001193125-25-253755.md) | [92.0 d](/filings/0001193125-26-048350.md) | [47.0](/filings/0001193125-26-185866.md) |
| Interest expense | $m | [21.0](/filings/0000950170-24-087179.md) | [23.0](/filings/0000950170-24-117316.md) | [23.0 d](/filings/0001193125-26-048350.md) | [24.0](/filings/0000950170-25-059817.md) | [22.0](/filings/0000950170-25-099476.md) | [21.0](/filings/0001193125-25-253755.md) | [24.0 d](/filings/0001193125-26-048350.md) | [22.0](/filings/0001193125-26-185866.md) | [22.0](/filings/0000950170-25-099476.md) | [22.0](/filings/0001193125-25-253755.md) | [22.0 d](/filings/0001193125-26-048350.md) | [22.0](/filings/0001193125-26-185866.md) |
| Income tax | $m | [19.0](/filings/0000950170-24-087179.md) | [48.0](/filings/0000950170-24-117316.md) | [(460) d](/filings/0001193125-26-048350.md) | [44.0](/filings/0000950170-25-059817.md) | [70.0](/filings/0000950170-25-099476.md) | [44.0](/filings/0001193125-25-253755.md) | [38.0 d](/filings/0001193125-26-048350.md) | [47.0](/filings/0001193125-26-185866.md) | [1.0](/filings/0000950170-25-099476.md) | [29.0](/filings/0001193125-25-253755.md) | [147 d](/filings/0001193125-26-048350.md) | [15.0](/filings/0001193125-26-185866.md) |
| Net income | $m | [155](/filings/0000950170-24-087179.md) | [114](/filings/0000950170-24-117316.md) | [598 d](/filings/0001193125-26-048350.md) | [119](/filings/0000950170-25-059817.md) | [226](/filings/0000950170-25-099476.md) | [130](/filings/0001193125-25-253755.md) | [160 d](/filings/0001193125-26-048350.md) | [73.0](/filings/0001193125-26-185866.md) | [108](/filings/0000950170-25-099476.md) | [42.0](/filings/0001193125-25-253755.md) | [(78.0) d](/filings/0001193125-26-048350.md) | [19.0](/filings/0001193125-26-185866.md) |
| Diluted EPS | $ per share | [0.39](/filings/0000950170-24-087179.md) | [0.29](/filings/0000950170-24-117316.md) | not reported | [0.30](/filings/0000950170-25-059817.md) | [0.57](/filings/0000950170-25-099476.md) | [0.33](/filings/0001193125-25-253755.md) | not reported | [0.19](/filings/0001193125-26-185866.md) | [0.29](/filings/0000950170-25-099476.md) | [0.11](/filings/0001193125-25-253755.md) | not reported | [0.05](/filings/0001193125-26-185866.md) |
| Basic EPS | $ per share | [0.39](/filings/0000950170-24-087179.md) | [0.29](/filings/0000950170-24-117316.md) | not reported | [0.30](/filings/0000950170-25-059817.md) | [0.57](/filings/0000950170-25-099476.md) | [0.33](/filings/0001193125-25-253755.md) | not reported | [0.19](/filings/0001193125-26-185866.md) | [0.29](/filings/0000950170-25-099476.md) | [0.11](/filings/0001193125-25-253755.md) | not reported | [0.05](/filings/0001193125-26-185866.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0000950170-23-035210.md) | [0.5](/filings/0000950170-23-055867.md) | [0.8](/filings/0000950170-25-021042.md) | [0.5](/filings/0000950170-24-048859.md) | [0.8](/filings/0000950170-24-087179.md) | [1.0](/filings/0000950170-24-117316.md) | [1.2](/filings/0001193125-26-048350.md) | [1.2](/filings/0000950170-25-059817.md) | [1.1](/filings/0000950170-25-099476.md) | [1.2](/filings/0001193125-25-253755.md) | [1.6](/filings/0001193125-26-185866.md) | [1.3](/filings/0001193125-26-185866.md) |
| Current assets | $bn | [5.6](/filings/0000950170-23-035210.md) | [5.7](/filings/0000950170-23-055867.md) | [5.8](/filings/0000950170-25-021042.md) | [5.7](/filings/0000950170-24-048859.md) | [5.8](/filings/0000950170-24-087179.md) | [5.9](/filings/0000950170-24-117316.md) | [5.8](/filings/0001193125-26-048350.md) | [5.8](/filings/0000950170-25-059817.md) | [5.8](/filings/0000950170-25-099476.md) | [5.8](/filings/0001193125-25-253755.md) | [5.8](/filings/0001193125-26-185866.md) | [5.7](/filings/0001193125-26-185866.md) |
| Total assets | $bn | [10.4](/filings/0000950170-23-035210.md) | [10.5](/filings/0000950170-23-055867.md) | [11.3](/filings/0001193125-26-048350.md) | [11.3](/filings/0000950170-25-059817.md) | [11.3](/filings/0000950170-25-099476.md) | [11.4](/filings/0001193125-25-253755.md) | [11.4](/filings/0001193125-26-048350.md) | [11.3](/filings/0001193125-26-185866.md) | [11.4](/filings/0000950170-25-099476.md) | [11.3](/filings/0001193125-25-253755.md) | [11.3](/filings/0001193125-26-185866.md) | [11.1](/filings/0001193125-26-185866.md) |
| Current liabilities | $bn | [2.4](/filings/0000950170-23-035210.md) | [2.4](/filings/0000950170-23-055867.md) | [2.4](/filings/0000950170-25-021042.md) | [2.3](/filings/0000950170-24-048859.md) | [2.2](/filings/0000950170-24-087179.md) | [2.3](/filings/0000950170-24-117316.md) | [2.3](/filings/0001193125-26-048350.md) | [2.2](/filings/0000950170-25-059817.md) | [2.2](/filings/0000950170-25-099476.md) | [2.3](/filings/0001193125-25-253755.md) | [2.4](/filings/0001193125-26-185866.md) | [2.3](/filings/0001193125-26-185866.md) |
| Total liabilities | $bn | [4.9](/filings/0000950170-23-035210.md) | [4.9](/filings/0000950170-23-055867.md) | [5.1](/filings/0000950170-25-021042.md) | [5.0](/filings/0000950170-24-048859.md) | [4.9](/filings/0000950170-24-087179.md) | [4.9](/filings/0000950170-24-117316.md) | [4.9](/filings/0001193125-26-048350.md) | [4.8](/filings/0000950170-25-059817.md) | [4.8](/filings/0000950170-25-099476.md) | [4.8](/filings/0001193125-25-253755.md) | [5.0](/filings/0001193125-26-185866.md) | [4.9](/filings/0001193125-26-185866.md) |
| Long-term debt | $bn | [1.7](/filings/0000950170-23-035210.md) | [1.7](/filings/0000950170-23-055867.md) | [1.7](/filings/0000950170-25-021042.md) | [1.8](/filings/0000950170-24-048859.md) | [1.7](/filings/0000950170-24-087179.md) | [1.7](/filings/0000950170-24-117316.md) | [1.7](/filings/0001193125-26-048350.md) | [1.7](/filings/0000950170-25-059817.md) | [1.7](/filings/0000950170-25-099476.md) | [1.7](/filings/0001193125-25-253755.md) | [1.7](/filings/0001193125-26-185866.md) | [1.7](/filings/0001193125-26-185866.md) |
| Current portion of debt | $bn | [0.0](/filings/0000950170-23-035210.md) | [0.0](/filings/0000950170-23-055867.md) | [0.0](/filings/0000950170-25-021042.md) | [0.0](/filings/0000950170-24-048859.md) | [0.0](/filings/0000950170-24-087179.md) | [0.0](/filings/0000950170-24-117316.md) | [0.0](/filings/0001193125-26-048350.md) | [0.0](/filings/0000950170-25-059817.md) | [0.0](/filings/0000950170-25-099476.md) | [0.0](/filings/0001193125-25-253755.md) | [0.0](/filings/0001193125-26-185866.md) | [0.0](/filings/0001193125-26-185866.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [5.4](/filings/0000950170-23-035210.md) | [5.5](/filings/0000950170-23-055867.md) | [6.2](/filings/0000950170-25-021042.md) | [6.2](/filings/0000950170-24-048859.md) | [6.4](/filings/0000950170-24-087179.md) | [6.5](/filings/0000950170-24-117316.md) | [6.4](/filings/0001193125-26-048350.md) | [6.4](/filings/0000950170-25-059817.md) | [6.5](/filings/0000950170-25-099476.md) | [6.5](/filings/0001193125-25-253755.md) | [6.3](/filings/0001193125-26-185866.md) | [6.2](/filings/0001193125-26-185866.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(72.0) d](/filings/0000950170-24-087179.md) | [40.0 d](/filings/0000950170-24-117316.md) | [377 d](/filings/0001193125-26-048350.md) | [(78.0)](/filings/0000950170-25-059817.md) | [432 d](/filings/0000950170-25-099476.md) | [359 d](/filings/0001193125-25-253755.md) | [591 d](/filings/0001193125-26-048350.md) | [135](/filings/0001193125-26-185866.md) | [191 d](/filings/0000950170-25-099476.md) | [352 d](/filings/0001193125-25-253755.md) | [573 d](/filings/0001193125-26-048350.md) | [(26.0)](/filings/0001193125-26-185866.md) |
| Capital expenditure | $m | [76.0 d](/filings/0000950170-24-087179.md) | [74.0 d](/filings/0000950170-24-117316.md) | [76.0 d](/filings/0001193125-26-048350.md) | [69.0](/filings/0000950170-25-059817.md) | [82.0 d](/filings/0000950170-25-099476.md) | [82.0 d](/filings/0001193125-25-253755.md) | [118 d](/filings/0001193125-26-048350.md) | [84.0](/filings/0001193125-26-185866.md) | [83.0 d](/filings/0000950170-25-099476.md) | [107 d](/filings/0001193125-25-253755.md) | [101 d](/filings/0001193125-26-048350.md) | [65.0](/filings/0001193125-26-185866.md) |
| Dividends paid | $m | [20.0 d](/filings/0000950170-24-087179.md) | [20.0 d](/filings/0000950170-24-117316.md) | [19.0 d](/filings/0001193125-26-048350.md) | [20.0](/filings/0000950170-25-059817.md) | [30.0 d](/filings/0000950170-25-099476.md) | [29.0 d](/filings/0001193125-25-253755.md) | [29.0 d](/filings/0001193125-26-048350.md) | [28.0](/filings/0001193125-26-185866.md) | [107 d](/filings/0000950170-25-099476.md) | [28.0 d](/filings/0001193125-25-253755.md) | [27.0 d](/filings/0001193125-26-048350.md) | [33.0](/filings/0001193125-26-185866.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [80.0 d](/filings/0001193125-25-253755.md) | [112 d](/filings/0001193125-26-048350.md) | [81.0](/filings/0001193125-26-185866.md) | [69.0 d](/filings/0000950170-25-099476.md) | [80.0 d](/filings/0001193125-25-253755.md) | [85.0 d](/filings/0001193125-26-048350.md) | [67.0](/filings/0001193125-26-185866.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [393](/filings/0000950170-23-035210.md) | [393](/filings/0000950170-23-055867.md) | [396](/filings/0000950170-24-048859.md) | [395](/filings/0000950170-24-087179.md) | [396](/filings/0000950170-24-117316.md) | [397](/filings/0000950170-25-059817.md) | [397](/filings/0000950170-25-099476.md) | [395](/filings/0001193125-25-253755.md) | [383](/filings/0001193125-26-185866.md) | [376](/filings/0000950170-25-099476.md) | [371](/filings/0001193125-25-253755.md) | [364](/filings/0001193125-26-185866.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 358,888,480 at 2026-04-24, from the cover of the [10-Q filed 2026-04-28](/filings/0001193125-26-185866.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.